Literature DB >> 28040462

Comparison between pediatric and adult adipose mesenchymal stromal cells.

Olivier Abbo1, Marion Taurand2, Paul Monsarrat3, Isabelle Raymond4, Emmanuelle Arnaud2, Sandra De Barros2, Françoise Auriol5, Philippe Galinier5, Louis Casteilla2, Valerie Planat-Benard6.   

Abstract

BACKGROUND: Adipose-derived mesenchymalstromal cells (ASC) are currently tested in regenerative medicine to promote tissue reconstruction after injury. Regardingautologous purpose, the possible loss of therapeutic function and cell properties during aging have been questioned in adults. To date no reliable information is available concerning ASC from pediatric patients and a better knowledge is required for clinical applications.
METHODS: Subcutaneous adipose tissue was collected from 27 donors (0-1 years old) and 50 donors (1-12 years old) and compared with adult ASC for in vitro characteristics. ASC were then tested in a mouse model of limb ischemia.
RESULTS: Cells from the stromal vascular fraction (SVF) and subsequent cultured ASC were prepared. Only a greater amount in SVF cell number and ASC proliferative rate were found. Cell phenotype, colony formingunit-fibroblast (CFU-F) content, immunomodulation effect and adipogenic, osteoblastic and angiogenic potentials were not significantly different. In vivo, pediatric ASC induced an increase in microangiographic score in a mouse model of limb ischemia, even though improvement in vascular density was not significantly correlated to limb rescue. Finally messengerRNA (mRNA) analysis using a microarray approach identified that only 305 genes were differentially expressed (217 down- and 88 up-regulated) in pediatric versus adult ASC, confirming that ASC from both age groups shared very close intrinsic properties.
CONCLUSION: This is the first study reporting a comparative analysis of ASC from a large number of donors and showing that their in vitro and in vivo properties were similar and maintained during aging.
Copyright © 2017 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  adipose mesenchymalstromal cells; cell therapy; pediatric cells

Mesh:

Year:  2016        PMID: 28040462     DOI: 10.1016/j.jcyt.2016.11.012

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  7 in total

1.  Fat Grafting into Younger Recipients Improves Volume Retention in an Animal Model.

Authors:  Natalie N Chung; Ryan C Ransom; Charles P Blackshear; Dre M Irizarry; Derek Yen; Arash Momeni; Gordon K Lee; Dung H Nguyen; Michael T Longaker; Derrick C Wan
Journal:  Plast Reconstr Surg       Date:  2019-04       Impact factor: 4.730

2.  Cellular Therapies for Treatment of Radiation Injury: Report from a NIH/NIAID and IRSN Workshop.

Authors:  Andrea L DiCarlo; Radia Tamarat; Carmen I Rios; Marc Benderitter; Christine W Czarniecki; Theresa C Allio; Francesca Macchiarini; Bert W Maidment; Jean-Rene Jourdain
Journal:  Radiat Res       Date:  2017-06-12       Impact factor: 2.841

Review 3.  Immunomodulatory Effect of Adipose-Derived Stem Cells: The Cutting Edge of Clinical Application.

Authors:  Simona Ceccarelli; Paola Pontecorvi; Eleni Anastasiadou; Claudio Napoli; Cinzia Marchese
Journal:  Front Cell Dev Biol       Date:  2020-04-17

Review 4.  Adipocyte-Based Cell Therapy in Oncology: The Role of Cancer-Associated Adipocytes and Their Reinterpretation as Delivery Platforms.

Authors:  Raluca Munteanu; Anca Onaciu; Cristian Moldovan; Alina-Andreea Zimta; Diana Gulei; Angelo V Paradiso; Vladimir Lazar; Ioana Berindan-Neagoe
Journal:  Pharmaceutics       Date:  2020-04-28       Impact factor: 6.321

5.  Characterization and functional analysis of the adipose tissue-derived stromal vascular fraction of pediatric patients with osteogenesis imperfecta.

Authors:  Josephine T Tauer; Hadil Al-Jallad; Mayumi Umebayashi; Dena Bakhsh; Damian Rauch; Simon D Tran; Frank Rauch; Reggie Hamdy
Journal:  Sci Rep       Date:  2022-02-14       Impact factor: 4.379

Review 6.  The Emerging Use of ASC/Scaffold Composites for the Regeneration of Osteochondral Defects.

Authors:  Gohar Rahman; Trivia P Frazier; Jeffrey M Gimble; Omair A Mohiuddin
Journal:  Front Bioeng Biotechnol       Date:  2022-06-30

7.  Osteogenic differentiation of human mesenchymal stromal cells and fibroblasts differs depending on tissue origin and replicative senescence.

Authors:  Vera Grotheer; Nadine Skrynecki; Lisa Oezel; Jan Grassmann; Joachim Windolf
Journal:  Sci Rep       Date:  2021-06-07       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.